NCT06935383View on ClinicalTrials.gov

Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
STEMI (ST Elevation MI)
Interventions
DEVICE

Therapeutic sequence

the required dose of treatment is administered through the CoFI system

DEVICE

Diagnostic sequence

Diagnostic sequence to detect MVO

Sponsors
All Listed Sponsors
lead

CorFlow Therapeutics AG

INDUSTRY